Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 2nd-line therapy. Found 5 abstracts

Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SR, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA. Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2012 Jun;10(6):703-13.   PMCID: not NIH funded
McGuire WP, Brady MF, Ozols RF. The Gynecologic Oncology Group experience in ovarian cancer. Annals of Oncology. 1999 Jan;10:29-34.
Ozols RF. Chemotherapy for ovarian cancer: Beyond paclitaxel plus carboplatin. Cancer Journal from Scientific American. 1999 Nov;5(6):336-8.
Ozols RF. Treatment of recurrent ovarian cancer: Increasing options - ''Recurrent'' results. Journal of Clinical Oncology. 1997 Jun;15(6):2177-80.
Corn BW, Lanciano RM, Boente M, Hunter WM, Ladazack J, Ozols RF. Recurrent Ovarian-Cancer - Effective Radiotherapeutic Palliation after Chemotherapy Failure. Cancer. 1994 Dec;74(11):2979-83.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 2nd-line therapy

Last updated on Wednesday, February 05, 2020